Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases

References

• Hennebert GL, Dessai BG. Lomentospora prolificans, a new hyphomycete from greenhouse soil. Mycotaxon 1974; 1: 50
   Google Scholar
• Malloch D, Salkin IF. A new species of Scedosporium associated with Osteomyelitis in Humans. Mycotaxon 1984; 21: 247–255
   Web of Science ®Google Scholar
• Gueho E, de Hoog GS. Taxonomy of the medical species of Pseudallescheria and Scedosporium. J Mycol Med 1991; 118: 3–9
   Google Scholar
• Berenguer J, Rodriguez-Tudela JL, Richard C, et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium prolificans Spanish Study Group. Medicine (Baltimore) 1997; 76: 256–265
   PubMed Web of Science ®Google Scholar
• Guarro J, Gaztelurrutia L, Marin J, Barcena J. [Scedosporium inflatum, a new pathogenic fungus. Report of 2 cases with a fatal outcome]. Enferm Infecc Microbiol Clin 1991; 9: 557–560
   PubMedGoogle Scholar
• Marin J, Sanz MA, Sanz GF, et al. Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia. Eur J Clin Microbiol Infect Dis 1991; 10: 759–761
   PubMed Web of Science ®Google Scholar
• Alvarez M, Lopez PB, Rayon C, et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J Clin Microbiol 1995; 33: 3290–3295
   PubMedGoogle Scholar
• Aranguena LG, Zurbano F, Cifrian JM, et al. [Colonization/infection of pulmonary graft by Scedosporium inflatum]. Enferm Infecc Microbiol Clin 1997; 15: 437–438
   Google Scholar
• Arthur S, Steed LL, Apple DJ, et al. Scedosporium prolificans keratouveitis in association with a contact lens retained intraocularly over a long term. J Clin Microbiol 2001; 39: 4579–4582
   Google Scholar
• Bouza E, Munoz P, Vega L, et al. Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor. Clin Infect Dis 1996; 23: 192–193
   PubMed Web of Science ®Google Scholar
• Carreter de Granda ME, Richard C, Conde E, et al. Endocarditis caused by Scedosporium prolificans after autologous peripheral blood stem cell transplantation. Eur J Clin Microbiol Infect Dis 2001; 20: 215–217
   Google Scholar
• Chikhani L, Dupont B, Guilbert F, et al. [Uncommon fungal maxillary sinusitis of dental origin due to Scedosporium prolificans]. Rev Stomatol Chir Maxillofac 1995; 96: 66–69
   Google Scholar
• de Batlle J, Motje M, Balanza R, Guardia R, Ortiz R. Disseminated infection caused by Scedosporium prolificans in a patient with acute multilineal leukemia. J Clin Microbiol 2000; 38: 1694–1695
   Google Scholar
• del Palacio A, Cuetara MS, Lumbreras C, Gonzalez A, Gomez C. [Transitory colonization by Scedosporium prolificans (inflatum) in a liver transplant recipient]. Enferm Infecc Microbiol Clin 1994; 12: 523–524
   Google Scholar
• del Palacio A, Garau M, Amor E, et al. Case reports. Transient colonization with Scedosporium prolificans. Report of four cases in Madrid. Mycoses 2001; 44: 321–325
   PubMedGoogle Scholar
• Diaz MC, Juliet C, Mdl TA, Rodriguez-Tudela JL. [Surgical site abscess by Scedosporium prolificans: first report in Chile and review]. Rev Chil Infect 2004; 21: 65–69
   Google Scholar
• Farag SS, Firkin FC, Andrew JH, Lee CS, Ellis DH. Fatal disseminated Scedosporium inflatum infection in a neutropenic immunocompromised patient. J Infect 1992; 25: 201–204
   PubMedGoogle Scholar
• Feltkamp MC, Kersten MJ, van der LJ, et al. Fatal Scedosporium prolificans infection in a leukemic patient. Eur J Clin Microbiol Infect Dis 1997; 16: 460–464
   Google Scholar
• Fernandez-Mosteirin N, Salvador-Osuna C, Mayayo P, Garcia-Zueco JC. [Scedosporium prolificans: disseminated infection in immunocompromised patient]. Med Clin (Barc) 2003; 120: 317–318
   PubMed Web of Science ®Google Scholar
• Garcia E, Rodriguez V, Gartner S, Gene J. [Isolation of Scedosporium prolificans in patients with cystic fibrosis]. Enferm Infecc Microbiol Clin 1998; 16: 488–489
   PubMedGoogle Scholar
• Gillum PS, Gurswami A, Taira JW. Localized cutaneous infection by Scedosporium prolificans (inflatum). Int J Dermatol 1997; 36: 297–299
   Google Scholar
• Gonzalez PA, del Palacio A, Perez Pomata MT, et al. [Fungemia caused by Scedosporium prolificans (inflatum) in a patient with AIDS]. Enferm Infecc Microbiol Clin 1998; 16: 382–383
   Google Scholar
• Gosbell IB, Toumasatos V, Yong J, et al. Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery. Mycoses 2003; 46: 233–236
   PubMed Web of Science ®Google Scholar
• Greig JR, Khan MA, Hopkinson NS, et al. Pulmonary infection with Scedosporium prolificans in an immunocompetent individual. J Infect 2001; 43: 15–17
   PubMed Web of Science ®Google Scholar
• Guerrero A, Torres P, Duran MT, et al. Airborne outbreak of nosocomial Scedosporium prolificans infection. Lancet 2001; 357: 1267–1268
   PubMedGoogle Scholar
• Hopwood V, Evans EG, Matthews J, Denning DW. Scedosporium prolificans, a multi-resistant fungus, from a U.K. AIDS patient. J Infect 1995; 30: 153–155
   PubMedGoogle Scholar
• Howden BP, Slavin MA, Schwarer AP, Mijch AM. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis 2003; 22: 111–113
   PubMed Web of Science ®Google Scholar
• Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: Emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003; 37: 221–229
   PubMed Web of Science ®Google Scholar
• Idigoras P, Lopez LC, Garcia-Arenzana JM, Diaz de Tuesta JL, Marin GJ. [Scedosporium inflatum disseminated infection]. Enferm Infecc Microbiol Clin 1993; 11: 285
   Google Scholar
• Idigoras P, Garcia-Arenzana JM, Saenz JR, Pineiro L, Marin J. [Isolation of Scedosporium prolificans from the air in the room of a patient with leukemia and disseminated infection with this fungus]. Enferm Infecc Microbiol Clin 2000; 18: 426–427
   Google Scholar
• Idigoras P, Perez-Trallero E, Pineiro L, et al. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, -1999. Clin Infect Dis; 32 1990; 2001: E158–E165
   Google Scholar
• Kumar B, Crawford GJ, Morlet GC. Scedosporium prolificans corneoscleritis: a successful outcome. Aust N Z J Ophthalmol 1997; 25: 169–171
   Google Scholar
• Lopez L, Gaztelurrutia L, Cuenca-Estrella M, et al. [Infection and colonization by Scedosporium prolificans]. Enferm Infecc Microbiol Clin 2001; 19: 308–313
   Google Scholar
• Maertens J, Lagrou K, Deweerdt H, et al. Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review. Ann Hematol 2000; 79: 340–344
   PubMed Web of Science ®Google Scholar
• Malekzadeh M, Overturf GD, Auerbach SB, Wong L, Hirsch M. Chronic, recurrent osteomyelitis caused by Scedosporium-inflatum. Ped Infect Dis J 1990; 9: 357–359
   PubMed Web of Science ®Google Scholar
• Marco dL, Sadaba P, Lastra Garcia-Baron P, et al. Cerebral scedosporiosis: an emerging fungal infection in severe neutropenic patients: CT features and CT pathologic correlation Eur Radiol 2006; 16: 496–502
   Google Scholar
• Moriarty AP, Crawford GJ, McAllister IL, Constable IJ. Severe corneoscleral infection. A complication of beta irradiation scleral necrosis following pterygium excision. Arch Ophthalmol 1993; 111: 947–951
   PubMed Web of Science ®Google Scholar
• Moriarty AP, Crawford GJ, McAllister IL, Constable IJ. Fungal corneoscleritis complicating beta-irradiation-induced scleral necrosis following pterygium excision. Eye 1993; 7: 525–528
   Google Scholar
• Nenoff P, Gutz U, Tintelnot K, et al. Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma. Mycoses 1996; 39: 461–465
   PubMedGoogle Scholar
• Nielsen K, Lang H, Shum AC, Woodruff K, Cherry JD. Disseminated Scedosporium prolificans infection in an immunocompromised adolescent. Pediatr Infect Dis J 1993; 12: 882–884
   Google Scholar
• Oliveira JS, Kerbauy FR, Colombo AL, et al. Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole. Braz J Med Biol Res 2002; 35: 789–798
   PubMedGoogle Scholar
• Pickles RW, Pacey DE, Muir DB, Merrell WH. Experience with infection by Scedosporium prolificans including apparent cure with fluconazole therapy. J Infect 1996; 33: 193–197
   PubMed Web of Science ®Google Scholar
• Rabodonirina M, Paulus S, Thevenet F, et al. Disseminated Scedosporium prolificans (S. inflatum) infection after single-lung transplantation. Clin Infect Dis 1994; 19: 138–142
   PubMed Web of Science ®Google Scholar
• Raunikar RA, Foshee WS. Scedosporium inflatum osteomyelitis-successful treatment with long-term amphotericin-B. Clin Res 1989; 37: A60
   Google Scholar
• Salesa R, Burgos A, Ondiviela R, et al. Fatal disseminated infection by Scedosporium inflatum after bone marrow transplantation. Scand J Infect Dis 1993; 25: 389–393
   PubMed Web of Science ®Google Scholar
• Sanchez AG, Martin CP, Jaurena J, et al. [About the article ‘Colonization/infection of a lung transplant by Scedosporium inflatum’]. Enferm Infecc Microbiol Clin 1998; 16: 251
   Google Scholar
• Simarro E, Marin F, Morales A, et al. Fungemia due to Scedosporium prolificans: a description of two cases with fatal outcome. Clin Microbiol Infect 2001; 7: 645–647
   PubMed Web of Science ®Google Scholar
• Singh RP, McCluskey P. Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C. Clin Exp Ophthalmol 2005; 33: 433–434
   PubMed Web of Science ®Google Scholar
• Sparrow SA, Hallam LA, Wild BE, Baker DL. Scedosporium inflatum: first case report of disseminated infection and review of the literature. Pediatr Hematol Oncol 1992; 9: 293–295
   PubMed Web of Science ®Google Scholar
• Spielberger RT, Tegtmeier BR, O'Donnell MR, Ito JI. Fatal Scedosporium prolificans (S. inflatum) fungemia following allogeneic bone marrow transplantation: report of a case in the United States. Clin Infect Dis 1995; 21: 1067
   Google Scholar
• Steinbach WJ, Schell WA, Miller JL, Perfect JR. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide. J Clin Microbiol 2003; 41: 3981–3985
   PubMed Web of Science ®Google Scholar
• Studahl M, Backteman T, Stalhammar F, Chryssanthou E, Petrini B. Bone and joint infection after traumatic implantation of Scedosporium prolificans treated with voriconazole and surgery. Acta Paediatr 2003; 92: 980–982
   PubMed Web of Science ®Google Scholar
• Sullivan LJ, Snibson G, Joseph C, Taylor HR. Scedosporium prolificans sclerokeratitis. Aust N Z J Ophthalmol 1994; 22: 207–209
   PubMedGoogle Scholar
• Tapia M, Richard C, Baro J, et al. Scedosporium inflatum infection in immunocompromised haematological patients. Br J Haematol 1994; 87: 212–214
   PubMed Web of Science ®Google Scholar
• Taylor A, Wiffen SJ, Kennedy CJ. Post-traumatic Scedosporium inflatum endophthalmitis. Clin Experiment Ophthalmol 2002; 30: 47–48
   PubMed Web of Science ®Google Scholar
• Toy EC, Rinaldi MG, Savitch CB. Leibovitch ER. Endocarditis and hip arthritis associated with Scedosporium inflatum. South Med J 1990; 83: 957–960
   PubMed Web of Science ®Google Scholar
• Westerman DA, Speed BR, Prince HM. Fatal disseminated infection by Scedosporium prolificans during induction therapy for acute leukemia: a case report and literature review. Pathology 1999; 31: 393–394
   PubMed Web of Science ®Google Scholar
• Wilson CM, O'Rourke EJ, McGinnis MR, Salkin IF. Scedosporium inflatum: clinical spectrum of a newly recognized pathogen. J Infect Dis 1990; 161: 102–107
   PubMed Web of Science ®Google Scholar
• Wise KA, Speed BR, Ellis DH, Andrew JH. Two fatal infections in immunocompromised patients caused by Scedosporium inflatum. Pathology 1993; 25: 187–189
   PubMed Web of Science ®Google Scholar
• Wood GM, McCormack JG, Muir DB, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992; 14: 1027–1033
   PubMed Web of Science ®Google Scholar
• Troke P, Aguirrebengoa K, Arteaga C, et al. Treatment of scedosporiosis with voriconazole: Clinical experience with 107 patients. Antimicrob Agents Chemother 2008; 52: 1743–1750
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Ruiz-Diez B, Martinez-Suarez JV, Monzon A, Rodriguez-Tudela JL. Comparative in vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 1999; 43: 149–151
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M. Combinations of antifungal agents in therapy – what value are they?. J Antimicrob Chemother 2004; 54: 854–869
   PubMed Web of Science ®Google Scholar
• DelPoeta M, Schell WA, Perfect JR. in vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob Agents Chemother 1997; 41: 1835–1836
   Google Scholar
• Johnson EM, Szekely A, Warnock DW. in vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998; 42: 741–745
   PubMed Web of Science ®Google Scholar
• Carrillo AJ, Guarro J. in vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother 2001; 45: 2151–2153
   PubMed Web of Science ®Google Scholar
• Meletiadis J, Meis JF, Mouton JW, et al. in vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 2002; 46: 62–68
   PubMed Web of Science ®Google Scholar
• Meletiadis J, Mouton JW, Rodriguez-Tudela JL, Meis JF, Verweij PE. in vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother 2000; 44: 470–472
   PubMed Web of Science ®Google Scholar
• Meletiadis J, Mouton JW, Meis JF, Verweij PE. in vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003; 47: 106–117
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Alastruey-Izquierdo A, Alcazar-Fuoli L, et al. in vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob Agents Chemother 2008; 52: 1136–1139
   PubMed Web of Science ®Google Scholar
• Gil-Lamaignere C, Roilides E, Maloukou A, et al. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 2002; 50: 1027–1030
   PubMed Web of Science ®Google Scholar
• Gil-Lamaignere C, Roilides E, Mosquera J, Maloukou A, Walsh TJ. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum. Antimicrob Agents Chemother 2002; 46: 2234–2237
   PubMed Web of Science ®Google Scholar
• Ortoneda M, Capilla J, Pujol I, et al. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans. J Antimicrob Chemother 2002; 49: 525–529
   PubMed Web of Science ®Google Scholar
• Ortoneda M, Capilla J, Pastor FJ, Serena C, Guarro J. Interaction of granulocyte colony-stimulating factor and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis. Diagn Microbiol Infect Dis 2004; 50: 247–251
   PubMed Web of Science ®Google Scholar
• Capilla J, Yustes C, Mayayo E, et al. Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits. Antimicrob Agents Chemother 2003; 47: 1948–1951
   PubMed Web of Science ®Google Scholar
• Simitsopoulou M, Gil-Lamaignere C, Avramidis N, et al. Antifungal activities of posaconazole and granulocyte-macrophage colon-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans. Antimicrob Agents Chemother 2004; 48: 3801–3805
   PubMed Web of Science ®Google Scholar